I love vaping. It's honestly my favorite way to consume cannabis. I still love flower, but the dependability and discreteness of a good vape pen makes it my go-to in most situations.

As cannabis use continues to rise across the world, more people are turning on to vaping as a discrete, potent alternative to traditional flower. Additionally, unlike weed, a vaporizer is ready at a moment's notice with no breaking up buds, packing bowls, or rolling joints. Another advantage is there are TONS of different cannabis or CBD oils you can use with your vaporizer that have no noticeable odor which makes them great for use in public or anywhere you'd like to use cannabis discretely.

So maybe you're interested in trying to vape for the first time or maybe you're just looking for some new gear. Either way, we've got you covered with a few suggestions based on customer satisfaction, performance, and style.

Quick look at the Best Vape Pens for 2020

Best Pen on a Budget: BeeKeeper 2.0 Multi-Color Limited Edition Oil Vaporizer

Best Device for Flower and Concentrates: Mamba 3-in-1 Vape Kit for Ejuice, Wax and Dry Herbs

Best concentrate device: Elf Auto Draw Conceal Oil Vaporizer

Most Discrete Vape: MiniMax Key Fob Battery

Let's take a closer look at each of these devices...

Best Pen on a Budget: BeeKeeper 2.0 Multi-Color Limited Edition Oil Vaporizer

This budget pen gets marks for positive reviews. Tauted as the "best on the market" by one reviewer, the BeeKeeper 2.0. Customers also mentioned the long-lasting battery and how compact it is.

Quick delivery and it’s perfect!! I have bought way too many mods or batteries for my cartridges and have NOT been happy...... this one IS THE ONE THAT’S MY KEEPER!!!!! Thank you so much. I’ve since ordered other items from them!

Check out the highlights:

• High Capacity 650mAh / 4V / 20W MOD Concealer
• Super car chameleon paint job
• High-performance 510 tank with stainless Mouthpiece and improved heater
• Ultra Wide Bore Opening to fit ALL THICK PREFILLED cartridges
• Slim unique design with quality build and feel.
• Most Rips & Awesome Flavor
• Proprietary low resistance magnet design for a stronghold and maximized electric current

Thank you, Austin, for taking the time to speak with Growers Network! Can you tell us a bit about your background and how you got involved in the CBD industry?

I received my BS in Behavioral Neuroscience at the University of Kansas. While there I worked in a medicinal chemistry lab focused on natural product synthesis. We extract the biologically active compounds from the salvia divinorum plant and use them to synthesize new compounds designed to treat pain without addictive properties. I then entered a PhD program in Neuroscience at the University of Arizona where I worked in a pharmacology lab focused on pain, opioids, addiction and cannabinoids. After a couple years of grad school I decided to change my path and leave the PhD program to received an MS in Neuroscience. This change included joining TruPotency as their director of science. I have always been interested in plant medicine and cannabis, so the transition to the CBD realm has been a smooth one.

There's a lot of confusion about the legality of CBD products. Can you clarify?

The 2018 Farm Bill states that cannabis products (from flower to tinctures) that have less than 0.3% THC, classified as hemp, are federally legal. However, certain states still classify hemp under their marijauna guidelines, which puts the residents of those states in a confusing situation. Although hemp and hemp based products are federally legal, states can and will have criminal charges for hemp and hemp based products.

What's the most common misconception people have about CBD?

There are a few general misconceptions that people who are unfamiliar with have, so here are some basic facts for those who are new to CBD.

1. Fact - CBD will not get you high.
2. Fact - CBD is non-addictive.
3. Fact - CBD is relatively safe.

Clinical trial participants have used over 800mg a day for months with little to no side-effects.

CBD is extremely popular right now. What are some other cannabinoids that are gaining traction in the industry?

There are over 100 cannabinoids, so as time moves on we will undoubtedly find benefits for others as well. Some others that are gaining popularity are CBDA, CBDV, THCV, and more. Depending on the testing lab, our current testing includes 11 to 15 different cannabinoids.

Cannabinol (CBN) is gaining popularity as a sleep aid and showing up in cannabinoid products claiming usefulness for sleep. TruPotency carries a brand called Plant People that has a sleep tincture designed with CBN.

Cannabigerol (CBG) is another cannabinoid that is becoming favored as well. Pre-clinical data suggests that this cannabinoid may be useful for pain and inflammation as well as acting as a muscle relaxant.

Cannabichromene (CBC) is also on the rise. This is another cannabinoids that may be beneficial for pain and inflammation.

How is TruPotency different than other online CBD retailers?

TruPotency sets ourselves apart in a few different ways. First, we are based on science. With a science advisory board consisting of MDs, PhDs, and wellness professionals, we use the latest data from clinical trials and scientific studies to vet the products we sell. We have pre-screened over 700 products, and selected 300 to be independently blind-tested tested and less than 20% of those pass the TruDiligence Testing and are available on TruPotency.com.

The TruPotency Science Team has developed a database of relevant cannabinoids, terpenes and other key ingredients and assigned a score for each product based on their contents based on clinical trials and published scientific research. The TruPotency algorithm uses these scores to determine which products are right for you. We are unique in this aspect using data to drive product scoring.

What was the most concerning thing you've discovered through you rigorous product testing?

First, there is a lot of bad products out there. Our data closely matches a University of Pennsylvania study that showed about 70 percent of CBD products are mislabeled. Customers want to know what they are buying is what is says it is. Not only properly labeled CBD, but some people cannot have THC due to work constraints, and some products claiming THC free showed THC in them.

The other issue is the variability between labs. You would hope that sending multiple of the same sample to big name labs would yield the same result, within reason, but that is not the case. Different lab can give wildly different results and products can be tested multiple times at multiple different labs. One concern I have is that companies are doing this until they get a result that fits the label claim, but the product is actually different, but the company has “proof” that the product is legitimate.

As an industry, we really need better rules and regulations for manufacturing and testing.

Any predictions for the future of the CBD market?

There have been and explosion of new CBD brands (over 1000 in 2019) with relatively little regulation. Our testing has shown how many poorly made products there are and brands that are around to make a quick buck on the CBD hype.

The FDA will be making decisions in the near (hopefully) future on the fate of CBD rules and regulations. I would hope that all hemp based products are fully legalized and regulated so we do not have to worry about the quality of a CBD product. When, and if, this happens, all the CBD brands that were riding on the CBD buzz will hopefully be out of business.

Soon, there might also be “craft” type products that mix CBD with other cannabinoids and terpenes at specific ratios to target certain effectiveness. Like mixing CBD, THC, and CBN, with linalool and myrcene as a sleep combination.

Growers Network would like to thank Austin and TruPotency for taking the time to answer our CBD questions. Do you have a question that you'd like to ask Austin? Click here to post a question you'd like Austin to answer during his Ask Me Anything session on our forum. It's happening on November 18th at 11AM Pacific, but even if you can't make it on the 18th, your pre-asked question will be answered! Hope to see you there!

CBD FAQ from Growers Network

Will CBD Oil make me high?
No. CBD is not a psychoactive compound whereas THC is. CBD is derived from hemp, which contains 0.3% THC maximum, a level too low to create any intoxicating effects.

Will CBD make me fail a drug test?
No. Drug screens for THC target a specific THC derivative, which will not be detectable with the minuscule amount of THC in hemp plants.

Is CBD Safe?
Yes. CBD has been scientifically tested and is shown to be safe with few side effects.

Where can I buy CBD?
CBD is available at a number of online and brick-and-mortar retailers. Look for proof of contents before purchasing as there are many non-tested and verified products on the market.

How do I take CBD?
CBD products are available in a variety of forms including tinctures, topicals, vape products, as CBD flower, patches, gummies, and more.

Permission Issued Under a Comprehensive Mexican Pharmaceutical License, Which Includes All Medicines for Health, Including Cannabis Products, Listed Under Groups I, I & III of the World Health Organization Categories of Medicine

Coquitlam, British Columbia--(Newsfile Corp. - October 2, 2019) - Captiva Verde Land Corp. (CSE: PWR) (the "Company" or "Captiva"), is pleased to announce that further to its news release of January 10, 2019, Captiva has executed and completed a share exchange agreement with Salud Esmeralda de Mexico SA de CV ("Esmeralda") for the exchange of all of the shares of Esmeralda for Eighty (80) Million common shares of Captiva. The shares are subject to a pooling agreement for one year.

Esmeralda and its team and advisors have over 200 years of experience in high level executive positions in Mexico, including energy, health, natural resources, government, business and the military.

Prior to this announcement, Esmeralda and its principals acquired from another Mexican corporation, a comprehensive pharmaceutical license to sell, market and distribute the entire suite of pharmaceutical, health, wellness and veterinarian products which include all psychoactive and non-psychoactive drugs listed under Groups I, II & III. These include a suite of over 300 medicines.

Captiva's sole mission is to provide all of Mexico with the highest quality medical products, including Cannabis products that are sourced from the best suppliers that have the highest proven efficacy all at the lowest possible prices to the Mexican consumer. In addition, Captiva Verde will ensure that all Cannabis products and other medical products meet the tough standards of the Mexican Health authorities.

Captiva management will dedicate the next several months to informing the Cannabis market and the general financial markets of the significance of this game changing license to import, wholesale and distribute.

On Behalf of the Board of Directors

"Jeff Ciachurski"
Jeffrey Ciachurski
Chief Executive Officer and Director
Cell: (949) 903-5906
E-mail: westernwind@shaw.ca

Cautionary Note Regarding Forward Looking Information
This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions.

Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.